Earnings summaries and quarterly performance for International Stem Cell.
Executive leadership at International Stem Cell.
Board of directors at International Stem Cell.
Research analysts covering International Stem Cell.
Recent press releases and 8-K filings for ISCO.
International Stem Cell Corporation Extends Maturity Date of Loan from CEO
ISCO
Debt Issuance
- International Stem Cell Corporation (ISCO) and Dr. Andrey Semechkin, the Company's Co-Chairman and Chief Executive Officer, agreed on September 15, 2025, to extend the maturity date of a loan.
- The loan, which originated from a promissory note dated September 15, 2024, now has a maturity date of September 15, 2026.
- The outstanding principal balance of the loan is $2,500,000.
- This principal accrues interest at an annual rate of 5.5%.
- Additionally, $799,064.44 in accrued and unpaid interest from the original note is carried forward, which will not accrue further interest under the new agreement.
Sep 16, 2025, 1:57 PM
Quarterly earnings call transcripts for International Stem Cell.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more